$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
赛可瑞要终身吃吗?
2025-10-19 11:44:20
Check Details
用赛可瑞多久会耐药?
2025-10-19 11:44:20
Check Details
特罗凯多少钱?
2025-10-19 11:44:20
Check Details
赛可瑞多少钱呢?
2025-10-19 11:44:20
Check Details
特罗凯一疗程多少钱?
2025-10-19 11:44:20
Check Details
肺癌靶向药赛可瑞说明书
2025-10-19 11:44:20
Check Details
靶向药赛可瑞多少钱一盒?
2025-10-19 11:44:20
Check Details
特罗凯一盒吃多久?
2025-10-19 11:44:20
Check Details
赛可瑞治疗什么病?
2025-10-19 11:44:20
Check Details
赛可瑞口服说明书
2025-10-19 11:44:20
Check Details
特罗凯2020年价格
2025-10-19 11:44:20
Check Details
赛可瑞耐药时间
2025-10-19 11:44:20
Check Details
1
2
...
3637
3638
3639
3640
3641
3642
3643
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
2
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
3
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
4
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
5
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
6
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
7
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
8
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
9
Cemiplimab (Libtayo) Drug Information
10
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
11
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
12
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers